335 related articles for article (PubMed ID: 34265371)
1. S. Typhi derived vaccines and a proposal for outer membrane vesicles (OMVs) as potential vaccine for typhoid fever.
Haque S; Swami P; Khan A
Microb Pathog; 2021 Sep; 158():105082. PubMed ID: 34265371
[TBL] [Abstract][Full Text] [Related]
2. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
3. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
4. IgA and IgG1 Specific to Vi Polysaccharide of
Dahora LC; Jin C; Spreng RL; Feely F; Mathura R; Seaton KE; Zhang L; Hill J; Jones E; Alam SM; Dennison SM; Pollard AJ; Tomaras GD
Front Immunol; 2019; 10():2582. PubMed ID: 31781100
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
Pakkanen SH; Kantele JM; Herzog C; Kantele A
Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
[TBL] [Abstract][Full Text] [Related]
6. Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead.
Syed KA; Saluja T; Cho H; Hsiao A; Shaikh H; Wartel TA; Mogasale V; Lynch J; Kim JH; Excler JL; Sahastrabuddhe S
Clin Infect Dis; 2020 Jul; 71(Suppl 2):S141-S150. PubMed ID: 32725225
[TBL] [Abstract][Full Text] [Related]
7. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
[TBL] [Abstract][Full Text] [Related]
8. Typhoid fever & vaccine development: a partially answered question.
Marathe SA; Lahiri A; Negi VD; Chakravortty D
Indian J Med Res; 2012; 135(2):161-9. PubMed ID: 22446857
[TBL] [Abstract][Full Text] [Related]
9. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever.
Howlader DR; Koley H; Sinha R; Maiti S; Bhaumik U; Mukherjee P; Dutta S
PLoS One; 2018; 13(9):e0203631. PubMed ID: 30216367
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
13. Vaccines against typhoid fever.
Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
[TBL] [Abstract][Full Text] [Related]
14. Typhoid and paratyphoid fever: a clinical seminar.
Manesh A; Meltzer E; Jin C; Britto C; Deodhar D; Radha S; Schwartz E; Rupali P
J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33550411
[TBL] [Abstract][Full Text] [Related]
15. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
Zuckerman JN; Hatz C; Kantele A
Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
[TBL] [Abstract][Full Text] [Related]
16. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
17. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of active component US military personnel against Salmonella Typhi.
Porter CK; Sorrell T; Mitra I; Riddle MS
Vaccine; 2017 Mar; 35(14):1742-1748. PubMed ID: 28268075
[TBL] [Abstract][Full Text] [Related]
19. Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012-19) before typhoid conjugate vaccine roll-out: a genomic epidemiology study.
Thilliez G; Mashe T; Chaibva BV; Robertson V; Bawn M; Tarupiwa A; Takawira FT; Kock MM; Midzi S; Mwamakamba LW; Matheu J; Juru A; Kingsley RA; Ehlers MM
Lancet Microbe; 2023 Dec; 4(12):e1005-e1014. PubMed ID: 37952554
[TBL] [Abstract][Full Text] [Related]
20. Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever.
Cross DL; Verheul MK; Leipold MD; Obermoser G; Jin C; Jones E; Starr JS; Mohorianu I; Blohmke CJ; Maecker HT; Napolitani G; Hill J; Pollard AJ
Front Immunol; 2020; 11():574057. PubMed ID: 33424833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
